Dr. Fox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
16040 Park Valley Dr.
B-100
Round Rock, TX 78681Phone+1 512-218-1222Fax+1 512-218-1222- Is this information wrong?
Education & Training
- Baylor College of MedicineResidency, Neurology, 1989 - 1992
- Baylor College of MedicineInternship, Internal Medicine, 1988 - 1989
- Baylor College of MedicineClass of 1988
Certifications & Licensure
- TX State Medical License 1990 - 2024
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Start of enrollment: 2007 Nov 01
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 1 citationsSerum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.Amit Bar-Or, Xavier Montalban, Xixi Hu, Harald Kropshofer, Petra Kukkaro, Neva Coello, Inga Ludwig, Roman Willi, Martin Zalesak, Krishnan Ramanathan, Bernd C Kieseier,...> ;Neurology and Therapy. 2023 Feb 1
- 2 citationsWorking to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristicsChristopher N. Sciamanna, Noel H. Ballentine, Melissa Bopp, Vernon M. Chinchilli, Joseph T. Ciccolo, Gabrielle Delauter, Abigail Fisher, Edward Fox, Suzanne M. Jan de ...> ;Trials. 2021 Nov 15
- 26 citationsRapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 studyAmit Bar-Or, Heinz Wiendl, Xavier Montalban, Enrique Alvarez, M. V. Davydovskaya, Silvia Delgado, E. P. Evdoshenko, Natasa Giedraitiene, Katrin Gross-Paju, Sulev Haldr...> ;Multiple Sclerosis. 2021 Oct 4
- Join now to see all
Press Mentions
- The University of Illinois School of Medicine Rockford Is Considering Adding a New $ 100 Million Building to Its Campus for Rural Health SciencesAugust 13th, 2021
- #AAN2019 — Ublituximab Safe, Well-Tolerated in Extension Study of Phase 2 Trial in Relapsing MSMarch 15th, 2019
- #ECTRIMS2018 – Ublituximab Markedly Reduces Lesions, Promotes B-cell Depletion, Halts Disability Progression in Phase 2 TrialSeptember 28th, 2018
- Join now to see all
Hospital Affiliations
- St. David's Round Rock Medical CenterRound Rock, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: